Velsecorat
- Generic Name
- Velsecorat
- Drug Type
- Small Molecule
- Chemical Formula
- C32H32F2N4O6
- CAS Number
- 1196509-60-0
- Unique Ingredient Identifier
- P30N0911C2
- Background
Velsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma).
A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT04072562
- Locations
- 🇩🇪
Research Site, Berlin, Germany
A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 36
- Registration Number
- NCT03976869
- Locations
- 🇺🇸
Research Site, Murray, Utah, United States
A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)Asthma
- Interventions
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 14
- Registration Number
- NCT02967159
- Locations
- 🇩🇪
Research Site, Berlin, Germany
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594
Phase 1
Completed
- Conditions
- SafetyPharmacokineticsPharmacodynamics of AZD7594
- Interventions
- Drug: Placebo to match
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 73
- Registration Number
- NCT01636024
- Locations
- 🇬🇧
Research Site, London, UK, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath